doravirine
Marketedupdated 2mo agoby Merck Sharp & Dohme Corp (Inactive)
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 1 investigational indication.
all catalysts(6)
approval · 6
Aug 30, 2018
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Sep 19, 2019
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Oct 10, 2019
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Jan 27, 2022
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Nov 7, 2024
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Oct 29, 2025
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
News(1)
- Merck adds to pharma’s AI push; Roche details MS drug results<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that